Benign prostatic hyperplasia (BPH) is characterized by an enlargement of the prostate gland that can lead to compression of the urethra.1 Patients often experience lower urinary tract symptoms (LUTS), which are typically classified as either voiding or storage symptoms.1
Over 60% of men will experience any LUTS.2 Although Asian men typically have smaller prostates compared with Western men, Asians experience similar or higher rates of LUTS that can impact sexual function and quality of life (QoL).1,3
At a recent morning tea symposium held in conjunction with the Malaysian Urological Conference 2016, Dr Marie Carmela Lapitan discussed about the benefits of combination therapy with alpha-blockers and 5-alpha-reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia (BPH).
Men with lower urinary tract symptoms (LUTS) are also found to be suffering from erectile dysfunction (ED), and studies show tadalafil 5 milligram once daily is safe and effective for the treatment of both LUTS due to benign prostate hyperplasia (BPH) plus coexisting ED.
Premature ejaculation (PE) is the most common sexual dysfunction in men, even more so than erectile dysfunction (ED), say experts in the field of men’s health. A survey which polled more than 3500 men and women from nine countries in the region reported that 1 in 3 men experience some form of PE.
Long-term testosterone replacement therapy (TRT) is beneficial in men with late-onset hypogonadism (LOH) in a study and is even associated with improvement in sexual function and vitality, physical pain, general health, and overall health-related quality of life (HRQoL).